These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1880231)
21. Pharmacokinetic parameters of ceftriaxone after single intravenous and intramuscular administration in camels (Camelus Dromedarius). Goudah A Res Vet Sci; 2008 Jun; 84(3):483-9. PubMed ID: 17765938 [TBL] [Abstract][Full Text] [Related]
22. Effect of caffeine on ceftriaxone disposition and plasma protein binding in the rat. Kwon KI; Bourne DW J Pharmacokinet Biopharm; 1986 Aug; 14(4):397-408. PubMed ID: 3689487 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients. Muder RR; Agarwala S; Mirani A; Gayowski T; Venkataramanan R J Clin Pharmacol; 2002 Jun; 42(6):644-50. PubMed ID: 12043952 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of ketoprofen in rats: effect of age and dose. Satterwhite JH; Boudinot FD Biopharm Drug Dispos; 1992 Apr; 13(3):197-212. PubMed ID: 1576328 [TBL] [Abstract][Full Text] [Related]
25. Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis. Ti TY; Fortin L; Kreeft JH; East DS; Ogilvie RI; Somerville PJ Antimicrob Agents Chemother; 1984 Jan; 25(1):83-7. PubMed ID: 6322683 [TBL] [Abstract][Full Text] [Related]
26. Explaining the poor bacteriologic eradication rate of single-dose ceftriaxone in group a streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling. Blumer JL; Reed MD; Kaplan EL; Drusano GL Pediatrics; 2005 Oct; 116(4):927-32. PubMed ID: 16199703 [TBL] [Abstract][Full Text] [Related]
27. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide. Giacomini KM; Swezey SE; Turner-Tamiyasu K; Blaschke TF J Pharmacokinet Biopharm; 1982 Feb; 10(1):1-14. PubMed ID: 7069575 [TBL] [Abstract][Full Text] [Related]
28. [Ceftriaxone in malignant occlusive jaundice. Studies of serum and bile concentration in disordered bile excretion]. Maikowski C; Rösch W; Sörgel F Fortschr Med; 1993 Nov; 111(32):513-6. PubMed ID: 8294078 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers. Chiu LM; Menhinick AM; Johnson PW; Amsden GW J Antimicrob Chemother; 2002 Dec; 50(6):1075-9. PubMed ID: 12461037 [TBL] [Abstract][Full Text] [Related]
30. Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis. Kovar A; Dalla Costa T; Derendorf H J Pharm Sci; 1997 Jan; 86(1):52-6. PubMed ID: 9002459 [TBL] [Abstract][Full Text] [Related]
31. Effect of probenecid on the elimination and protein binding of ceftriaxone. Stoeckel K; Trueb V; Dubach UC; McNamara PJ Eur J Clin Pharmacol; 1988; 34(2):151-6. PubMed ID: 3383987 [TBL] [Abstract][Full Text] [Related]